Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of liraglutide on MMC activity and gastrointestinal hormones in healthy volunteers
2018-001949-13Phase 4Active
- Sponsor
- KU Leuven
- Start
- Jan 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in obesity comparing Liraglutide with Placebo (2 arms). Primary endpoint: MMC activity. Started Jan 2019; status: active.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on 2018-001949-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001949-13.